Your answers are used to assess whether treatment may be suitable for you, including BMI, medical history, current medicines and previous weight loss treatments
Novo Nordisks collaboration with United Laboratories International focuses on UBT251, a triple agonist targeting GLP-1, GIP, and glucagon receptors
Analyzing mitochondrial dysfunction, oxidative stress, and apoptosis: potential role of L-carnitine
3
PlexusDx's Precision Peptide Genetic Test can identify your individual peptide-pathway predispositions (analyzing variants in GIPR and FTO, and MC4R genes), which helps personalize whether long-term treatment or a break-and-restart approach better suits your biology
The right answer comes from proper testing, not assumptions